Skip to Main Content
Contribute Try STAT+ Today

Key insight: PD-L1, a molecular target of cancer immunotherapy, is so closely tied to pain in animal experiments, scientists think it may mean the more pain is felt, the better the treatment is working.

Pain exists for a reason: It alerts us that something’s gone awry in our bodies. Now, a new study suggests that some cancers might block our ability to sense the pain that radiates from a tumor —allowing it to continue growing, surreptitiously.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Yep. As if people with cancer haven’t been manipulated, conned, and taken advantage of physically, emotionally and financially enough. Always another entity looking for what money you have left. Disgusting!

  • Since this is for subscription only readers, is there at least a reference to a journal article we can read for more information? Please!

  • Wow. Pretending to be an accessible article on the Globe main page and then demanding we subscribe to something completely separate from the Globe if we want to see it? Dirty trick.

  • Why masquerade as a Globe article and then not let people read the it? Hint: don’t go out of your way to look like you have your hand out for our hard earned dollars before you show you’re worth it. Right now, that would be a nope.

    • Trick articles are a good way to reduce STAT subscribers. I have to wade thru enough crap; not doing it here

Comments are closed.